31 results on '"Sobel, Rachel E."'
Search Results
2. Risk of carpal tunnel syndrome among patients with osteoarthritis: a US population-based study
3. Comparative effectiveness of linvoseltamab versus standard-of-care (SOC) treatment (tx) in real-world patients (pts) in the United States (US) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM).
4. A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect® additional risk minimisation measures
5. Using EHR data to identify coronavirus infections in hospitalized patients: Impact of case definitions on disease surveillance
6. A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool
7. PB2281: TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN RELAPSED/REFRACTORY PATIENTS TREATED WITH SYSTEMIC THERAPY IN A REAL-WORLD ASSESSMENT (FLORA)
8. PB2357: TRIAL IN PROGRESS: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH SYSTEMIC THERAPY FROM REAL-WORLD EXPERIENCE (ORCHID)
9. Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey
10. Real World Evidence: Time for a Switch?
11. Regulatory and HTA Considerations for Development of Real‐World Data Derived External Controls
12. A Case Study of the Incremental Utility for Disease Identification of Natural Language Processing in Electronic Medical Records
13. Computer-assisted expert case definition in electronic health records
14. Trial in Progress: Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Systemic Therapy from Real-World Experience (ORCHID)
15. Trial in Progress: Follicular Lymphoma Outcomes in Relapsed/Refractory Patients Treated with Systemic Therapy in a Real-World Assessment (FLORA)
16. Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel Systemʼs analytic tools
17. A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting.
18. Current needs in pediatric pharmacoepidemiology
19. A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect® additional risk minimisation measures.
20. The utility of real‐world evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studies
21. The Role of Pharmacoepidemiology in Industry
22. The Role of Pharmacoepidemiology in Industry
23. FcgammaRIIA Polymorphism as a Risk Factor for Invasive Pneumococcal Infections in Systemic Lupus Erythematosus
24. A Case Study of the Incremental Utility for Disease Identification of Natural Language Processing in Electronic Medical Records.
25. Novel Method to Collect Medication Adverse Events in Juvenile Arthritis: Results From the Childhood Arthritis and Rheumatology Research Alliance Enhanced Drug Safety Surveillance Project
26. Using Registries to Identify Adverse Events in Rheumatic Diseases
27. Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: Time for a consolidated patient registry
28. Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular events
29. 697: Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for Erectile Dysfunction: A Review of > 44,800 Patients in Clinical and Observational Studies
30. NAION and treatment of erectile dysfunction: reply from Pfizer.
31. Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.